China Medical City Taizhou, Jiangsu, China

Global Top-tier Commercialization Hub in Life Science Industry

CONTENT

Profile of CMC 01 Achievements of CMC 02

Characteristics of CMC 03

Profile of CMC

Location

CMC

Location - center of Jiangsu Province, north to the Yangtze River

Transportation - 2.5 hours to Shanghai by expressway - 1.5 hours to Nanjing by expressway

Important hub of Yangtze River Delta

- a new commercial and industrial city Location: Center of Jiangsu Area: 5793 km2 Population: 5.07 million

Transportation

Transportation Network

Yangzhou-Taizhou Int’l Airport（40）

Shanghai Pudong Int’l Airport（220）

Zhengjiang Railway Station（75）

Nanjing Lukou Int’l Airport（150）

Wuxi Int’l Airport（125）

Shanghai Hongqiao Int’l Airport（150）

Taizhou Port（15） Hutong Railway Bridge Changzhou Railway Station（80） - - - - - - - - - - - - -

- - - - - - - - - - -

- - - - - - - - - - - - - - - -

- - - - - - - - - - - - - - - -

- - - - - - - - - - - - - - - - - - - - - - - - - -

- - - - - - - - - - - - - - - - - - - - - - - -

- - - - - - - - - - - - - - - - - - -

- - -

*The numbers in parentheses means the distance in kilometers.

Strategic Decision

Infrastructure Construction

National-level Park

18 k㎡，800+ Projects

2005

2006

2009

2017

Milestone

Functional Areas

R & D Area

Exhibition & Trade Area

Education Area

Functional Areas: 30km2 Put into operation: 18km2

Achievements of CMC

The First national medical park

The Unique park jointly built by four ministries and Jiangsu government

The Unique Jiangasu FDA CMC branch

The First national new vaccine and specific diagnostic reagents industry cluster development pilot The only pilot city in Yangtze River economic zone with large health industry cluster

2010年

2011年

2013年

2016年

2017年

2009年

The first "Regional Innovation Center (RRC)" to be set up by United Nations International Center for Genetic Engineering and Biotechnology (ICGEB)

Glories

• 800+ Bio-related Companies Gathering in CMC

阿斯利康 武田中国 中外制药 勃林格殷格翰 雀巢 高德美

Global Industrial Giants

Project Investment

Astra Zeneca 230 Million USD

Boehringer-Ingelheim 100 Million USD

Nestle 560 Million RMB

GALDEMAR 500 Million RMB

• Projects Investment in Total: 34 Billion RMB (~5 Billion USD)

CMC Growth

150,25 171,3

195,22

00,020,040,060,080,10,120,140,160,180,2

0

50

100

150

200

250

2014 2015 2016

GDP(亿元)

132 drug production enterprises in total, of which 31

obtained production licenses.

272 medical device enterprises, of which 82 obtained

production licenses and officially put into operation.

602 medical device registration certificates

180 medical device sales companies

13 vaccine research and development production

enterprises (more than 40 varieties)

10 "food production license" (including health care

products)

4 cosmetics production licenses

1 drug logistics company

0100200300400500600700

medical deviceregistration

certificates approval

Drug clinicalapproval

Drug productionapproval

Drug registrationapplication

12

More than 1,000 innovative achievements successfully approved

Heimpefen is one of the two new 1.1 categories of new drugs obtained in 2016. Influenza virus lysis vaccine (tetravalent) is one of the only two varieties of vaccine produced in 2016. HPV vaccine by Ruike is one of the 10 vaccine varieties of clinical trial application in the whole China in 2016. PD1 monoclonal antibody by Junhe Bio-company as the first to get clinical trial approved in domestic.

Over the past five years, the application number of biological products accounted for 1/4 in Jiangsu Province, and in 2016, 60% among Jiangsu, 6.7% of the China. The biological products application number is 7, of which 4 belong to CMC, from Jan. to May in 2017.

050

100150200250300350400

year 2012 year 2013 year 2014 year 2015 year 2016

total registration number

0

10

20

30

40

50

60

Class I new drug Class I clinical trialapprovement

Class III medicaldevice certificate

Special job fair for

companies

CMC head-hunting

company

Multiple Talent

Programs

Talents

14

After 10 years of development, CMC has become a brand of biomedical field

in China. The well-known achievements make great promotion to the whole

society.

Achievements

Characteristics of CMC

Fast Clustering

Ministry of Science and Technology

National Health and Family Planning Commission

State Administration of Traditional Chinese Medicine

China Food and Drug Administration

Jiangsu Provincial Government

Jointly Supported by Ministries

Regulation Support

Policy for Special Project Channel

for Application

Jiangsu Institute for Food and Drug Control CMC Branch Jiangsu Provincial Medical Instrument Testing Institute CMC Branch • Diagnostic Reagent Testing Center

Regulation Support

National Patent Strategic Promotion and Service Center (Taizhou)

Taizhou Center was built by State Intellectual Property Office and Jiangsu IPO.

※ patent application ※ IP protection and legal aid ※ subsidies for patent invention application fee

complete academic technology service platform

Company Management

Government Guidline International

Target

Professional Management

Marketing Operation

Professional Technology Platform

16 public service platforms have been put into operation,

including R&D, manufacturing, sales, exhibition, which provide a one-stop

service for companies.

Partners and Fund Support

1000+ senior manager of manufacturing and distribution companies

5 companies (JianXin Inc. & Rongjianda Inc. etc.) , 1.5 billion RMB

Talent Support

1. Talent program The Recruitment Program of Global Experts-Thousand Talents Program Hundred Talent Program for Oversea Expert Innovative and Entrepreneurial Talent Program “113” Talent Program 2.Talent recruitment and Training Special job fair for companies CMC head-hunting company Employment alliance of universities in Jiangsu “Jiangsu Green Card” for Foreign Experts Training Programs for cultivation of highly skilled human resources

Exceptional Incentive Package

01

04

03

05

02

06

Decorated Lab and GMP Standard Workshop for lease

Service Provider

Reward for product varieties (Drug, Vaccine, Medical Device, TCM) Tax benefits

Financial assistance Special incentives for researchers with outstanding performance

Provision of optimal living conditions

CONTACT

Snímek číslo 1Snímek číslo 2Snímek číslo 3Snímek číslo 4Snímek číslo 5Snímek číslo 6Snímek číslo 7Snímek číslo 8Snímek číslo 9Snímek číslo 10Snímek číslo 11Snímek číslo 12Snímek číslo 13Snímek číslo 14Snímek číslo 15Snímek číslo 16Snímek číslo 17Snímek číslo 18Snímek číslo 19Snímek číslo 20Snímek číslo 21Snímek číslo 22Snímek číslo 23Snímek číslo 24